Antidepressant-Induced Sexual Dysfunction

Gregorian, Razmic S; Golden, Katharine A; Bahce, Asena; Goodman, Clifford; Kwong, W Jacqueline; Khan, Zeba M

doi:10.1345/aph.1a195

Cited by 407Sexual function and dysfunction studiesTreatment of Major DepressionSchizophrenia research and treatment

The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.

Antidepressant-Induced Sexual Dysfunction

Gregorian, Razmic S, Golden, Katharine A, Bahce, Asena, Goodman, Clifford, Kwong, W Jacqueline, Khan, Zeba M·2002·Annals of Pharmacotherapy

DOI 10.1345/aph.1a195

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To review the evidence regarding antidepressant-induced sexual dysfunction and address implications for treatment strategy and health plan coverage policies for antidepressant medications. DATA SOURCES: Primary articles were identified by a MEDLINE and HealthSTAR search to identify English-language studies published between January 1986 and July 2000. Search terms included sexual dysfunction or sexual function and antidepressants, fluoxetine, sertraline, paroxetine, fluvoxamine, citalopram, venlafaxine, nefazodone, bupropion, and mirtazapine. A cross-check of references cited in 10 published reviews yielded additional in-scope articles. STUDY SELECTION AND DATA EXTRACTION: Approximately 200 articles were identified, including 8 randomized controlled trials and numerous open-label studies, case series, and case reports. Of the randomized controlled trials, only 5 were designed to evaluate the incidence of sexual dysfunction associated with antidepressant treatment. Three additional randomized controlled trials included a structured assessment of sexual dysfunction within an efficacy trial. Data extraction excluded case reports, letters, and other limited study designs. A panel survey augmented published reports. DATA SYNTHESIS: Sexual dysfunction is a relatively common adverse effect of many of the antidepressants in common use today. Rates of sexual dysfunction observed in clinical practice may be higher than those reported in the product information for several agents. Selective serotonin-reuptake inhibitors (SSRIs) appear to be the class of antidepressants most likely to cause sexual dysfunction. Published studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction. Bupropion and nefazodone appear to be much less likely to cause sexual dysfunction (≤10% of patients). Mirtazapine also appears to be associated with a low rate of sexual adverse effects. Panel results largely reflect the consensus of the literature. CONCLUSIONS: Sexual dysfunction is a common adverse effect of antidepressant treatment. Physicians should monitor their patients for antidepressant-induced sexual adverse effects, as these may affect compliance with therapy and ultimate treatment success. In addition to the consequences for patient health and well-being, managed-care organizations should be concerned with sexually related adverse effects of antidepressants, insofar as additional healthcare resources may be required to treat depressed patients in whom these adverse effects arise.

Integrity signals

Registry

Crossref · 10.1345/aph.1a195

Cites

206 of 206 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Published studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction.
“Published studies suggest that between 30% and 60% of SSRI-treated patients may experience some form of treatment-induced sexual dysfunction (553,554).”
From Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (2011) · cites this paper as [554]
Some side-effects such as increased agitation and sexual dysfunction can be especially distressing for people with social anxiety disorder.
“Some side-effects such as increased agitation18 and sexual dysfunction20 can be especially distressing for people with social anxiety disorder”
From Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis (2014) · cites this paper as [20]

Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐II
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
A simulation study of the number of events per variable in logistic regression analysis
Peduzzi, P., Concato, J., Kemper, E., Holford, T. R., & Feinstein, A. R. (1996) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00236-3 · Cited by 9,655
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.
Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833
Physicians Desk Reference
Arky, R. A. (1994) · Cited by 2,632
Drug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622
Handbook of Religion and Health
Koenig, H., McCullough, M., & Larson, D. (2001) · doi:10.1093/acprof:oso/9780195118667.001.0001 · Cited by 2,581
Self-citation
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
Anderson, J. W., Johnstone, B. M., & Cook-Newell, M. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330502 · Cited by 2,048
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence
Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993) · Pain · doi:10.1016/0304-3959(93)90161-h · Cited by 1,966
Toward a Comprehensive Model of Change
Prochaska, J. O., & Diclemente, C. C. (1986) · Treating Addictive Behaviors · doi:10.1007/978-1-4613-2191-0_1 · Cited by 1,877
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol Levels
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F. M., Moye, L. A., Goldman, S., Flaker, G. C., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.98.9.839 · Cited by 1,389
THE ASSOCIATION OF SOCIAL RELATIONSHIPS AND ACTIVITIES WITH MORTALITY: PROSPECTIVE EVIDENCE FROM THE TECUMSEH COMMUNITY HEALTH STUDY
HOUSE, J. S., ROBBINS, C., & METZNER, H. L. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113387 · Cited by 1,381
Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione
Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Blood Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden Death
Albert, C. M., Campos, H., Stampfer, M. J., Ridker, P. M., Manson, J. E., Willett, W. C., & Ma, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012918 · Cited by 1,146
The hemophilias--from royal genes to gene therapy
Mannucci, P. M., & Tuddenham, E. G. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106073442307 · Cited by 1,110
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Polyunsaturated fatty acids in the food chain in the United States
Kris-Etherton, P., Taylor, D. S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., Hargrove, R. L., Zhao, G., & Etherton, T. D. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.179s · Cited by 1,023
Fish Consumption and Risk of Sudden Cardiac Death
Albert, C. M. (1998) · JAMA · doi:10.1001/jama.279.1.23 · Cited by 990
Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat: A Randomized Controlled Trial
Davidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947
Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy: A Review of the Literature and Pathophysiology
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910
Trends in the Prescribing of Psychotropic Medications to Preschoolers
Zito, J. M. (2000) · JAMA · doi:10.1001/jama.283.8.1025 · Cited by 863
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger, M. A., Blumenstein, B. A., Crawford, E. D., Miller, G., McLeod, D. G., Loehrer, P. J., Wilding, G., Sears, K., Culkin, D. J., Thompson, I. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391504 · Cited by 859
A Multifaceted Intervention to Improve Treatment of Depression in Primary Care
Katon, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100072009 · Cited by 835
Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
Management of Dyslipidemia in Adults With Diabetes
Haffner, S. M. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.160 · Cited by 786
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Human Pharmacology and Abuse Potential of the Analgesic Buprenorphine: A Potential Agent for Treating Narcotic Addiction
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Johnson, A. G., Nguyen, T. V., & Day, R. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00011 · Cited by 717
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women
Hu, F. B., Stampfer, M. J., Manson, J. E., Ascherio, A., Colditz, G. A., Speizer, F. E., Hennekens, C. H., & Willett, W. C. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.6.1001 · Cited by 661
Effects of SSRIs on Sexual Function
Rosen, R. C., Lane, R. M., & Menza, M. A. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199902000-00013 · Cited by 654
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., et al. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200107000-00010 · Cited by 641
Self-citation
Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome
Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., Fiorini, S., Cognigni, G. E., Filicori, M., & Morselli-Labate, A. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6738 · Cited by 635
Effective Medical Treatment of Opiate Addiction
Addiction, N. C. D. P. O. E. M. T. O. O. (1998) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.280.22.1936 · Cited by 577
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542
The Exclusion of the Elderly and Women From Clinical Trials in Acute Myocardial Infarction
Gurwitz, J. H. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490110055029 · Cited by 532
Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men
Perry, I. J., Wannamethee, S. G., Walker, M. K., Thomson, A. G., Whincup, P. H., & Shaper, A. G. (1995) · BMJ · doi:10.1136/bmj.310.6979.560 · Cited by 532
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527
International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program
Pfaller, M. A., Diekema, D. J., Jones, R. N., Sader, H. S., Fluit, A. C., Hollis, R. J., Messer, S. A., & The SENTRY Participant Group (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3254-3259.2001 · Cited by 521
Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
Montejo-gonzàlez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De LA Gandara, J., et al. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403923 · Cited by 505
Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs
Perneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484
Effects of St. John's wort on irinotecan metabolism.
Mathijssen, R. H. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.16.1247 · Cited by 457
A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood Disorders
Frye, M. A., Ketter, T. A., Kimbrell, T. A., Dunn, R. T., Speer, A. M., Osuch, E. A., Luckenbaugh, D. A., Corá-Locatelli, G., Leverich, G. S., & Post, R. M. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00004 · Cited by 446
Neuroleptic Withdrawal in Schizophrenic Patients
Gilbert, P. L. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950150005001 · Cited by 434
Physicians and Patient Spirituality: Professional Boundaries, Competency, and Ethics
Post, S. G., Puchalski, C. M., & Larson, D. B. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00010 · Cited by 417
Self-citation
Methadone Maintenance vs 180-Day Psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial
Sees, K. L., Delucchi, K. L., Masson, C., Rosen, A., Clark, H. W., Robillard, H., Banys, P., & Hall, S. M. (2000) · JAMA · doi:10.1001/jama.283.10.1303 · Cited by 415
Antibiotic-Associated Diarrhea
Bartlett, J. G. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.4.573 · Cited by 414
Low‐dose indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial
Ment, L. R., Ehrenkranz, R. A., Duncan, C. C., Scott, D. T., Taylor, K. J. W., Katz, K. H., Schneider, K. C., Makuch, R. W., Oh, W., Vohr, B., et al. (1994) · Pediatrics · doi:10.1542/peds.93.4.543 · Cited by 385
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368
Metoclopramide
Harrington, R., Hamilton, C. W., Brogden, R. N., Linkewich, J. A., Romankiewicz, J. A., & Heel, R. C. (1983) · Drugs · doi:10.2165/00003495-198325050-00002 · Cited by 359
Data, Design, and Background Knowledge in Etiologic Inference
Robins, J. M. (2001) · Epidemiology · doi:10.1097/00001648-200105000-00011 · Cited by 358
The stigma of epilepsy: a European perspective
Baker, G. A., Brooks, J., Buck, D., & Jacoby, A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01512.x · Cited by 357
Metoclopramide: Pharmacology and Clinical Application
Albibi, R., & McCallum, R. W. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-1-86 · Cited by 354
Religion and mortality among the community-dwelling elderly.
Oman, D., & Reed, D. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.10.1469 · Cited by 350
Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study
Rzany, B., Correia, O., Kelly, J. P., Naldi, L., Auquier, A., & Stern, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05418-x · Cited by 348
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
Kaesemeyer, W. H., Caldwell, R. B., Huang, J., & Caldwell, R. W. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00514-2 · Cited by 343
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Preskorn, S. (1995) · PubMed · Cited by 327
Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study
Ghirlanda, G., Oradei, A., Manto, A., Lippa, S., Uccioli, L., Caputo, S., Greco, A. V., & Littarru, G. P. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03948.x · Cited by 324
Autism
Rapin, I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370206 · Cited by 319
Comparison of pharmacodynamic properties of various estrogen formulations
Mashchak, C. A., Lobo, R. A., Dozono-Takano, R., Eggena, P., Nakamura, R. M., Brenner, P. F., & Mishell, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90218-6 · Cited by 316
Adverse events and their association with treatment regimens in the diabetes control and complications trial
(1995) · Diabetes Care · doi:10.2337/diacare.18.11.1415 · Cited by 305
Factors Predictive of Long-Term Coronary Heart Disease Mortality among 10,059 Male Israeli Civil Servants and Municipal Employees
Goldbourt, U., Yaari, S., & Medalie, J. H. (2008) · Cardiology · doi:10.1159/000175862 · Cited by 304 · cited 1×
“17 For both genders, weekly attendance was associated with a statistically significant improvement in (1) quitting smoking, (2) becoming frequently physically active, (3) alleviation of depression, (4) increasing the number of individual personal relationships, and (5) initiating and sustaining stable marriages (Table…”
Background
Fish oil and glycemic control in diabetes. A meta-analysis.
Friedberg, C. E., Janssen, M. J. F. M., Heine, R. J., & Grobbee, D. E. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.494 · Cited by 303
Effects of inhaled glucocorticoids on bone density in premenopausal women.
Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., & LeBoff, M. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002304 · Cited by 303
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.1.16 · Cited by 301
Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors
Muller, P., & Seeman, P. M. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90155-2 · Cited by 299
Metoclopramide: Pharmacology and clinical application
Bullard, D. E. (1983) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(83)90196-9 · Cited by 295
Mental Disorders and Mental Health Treatment Among U.S. Department of Veterans Affairs Outpatients: The Veterans Health Study
Hankin, C. S., Spiro, A., Miller, D. R., & Kazis, L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1924 · Cited by 289
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287
Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
GLAUBER, H., WALLACE, P., GRIVER, K., & BRECHTEL, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-663 · Cited by 285
Relationship of childhood maltreatment to the onset and course of major depression in adulthood
Bernet, C. Z., & Stein, M. B. (1999) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1999)9:4 · Cited by 282
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
Malmberg, K., Ryden, L., Hamstent, A., Herlitz, J., Waldenstrom, A., Wedel, H., & on behalf of the DIGAMI study group (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015067 · Cited by 281
SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+ · Cited by 278
Effects of psychotropic drugs on human erection and ejaculation.
Segraves, R. T. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030081011 · Cited by 277
The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders
Ganzini, L. K. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410120051007 · Cited by 266
Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
Reimherr, F. W., Chouinard, G., Cohn, C. K., Cole, J. O., Itil, T. M., LaPierre, Y. D., Masco, H. L., & MENDELS, J. (1990) · PubMed · Cited by 263
Safety Review of Adult Clinical Trial Experience with Lamotrigine
Messenheimer, J., Mullens, E. L., Giorgi, L., & Young, F. (1998) · Drug Safety · doi:10.2165/00002018-199818040-00004 · Cited by 252
Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment
Viguera, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130055011 · Cited by 246
A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline
Croft, H. A., Settle, E. C., Houser, T. L., Batey, S. R., Donahue, R. M. J., & Ascher, J. A. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)88317-4 · Cited by 244
Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus
Fujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., & Group, T. S. C. S. (2000) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00081.x · Cited by 244
Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
Jacobsen, F. M. (1992) · PubMed · Cited by 236
Does religious observance promote health? mortality in secular vs religious kibbutzim in Israel.
Kark, J. D., Shemi, G., Friedlander, Y., Martin, O., Manor, O., & Blondheim, S. H. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.3.341 · Cited by 226
Neuroleptic-induced supersensitivity psychosis
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1409 · Cited by 224
Initiation of Antihypertensive Treatment During Nonsteroidal Anti-inflammatory Drug Therapy
Gurwitz, J. H. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520100043031 · Cited by 220
Lamotrigine plasma levels reduced by oral contraceptives
Sabers, A., Buchholt, J. M., Uldall, P., & Hansen, E. L. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00305-9 · Cited by 219
Outcome of Depression and Anxiety in Primary Care: A Three-Wave 31/2-Year Study of Psychopathology and Disability
Ormel, J. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820220009001 · Cited by 216
Anorgasmia from Clomipramine in Obsessive-Compulsive Disorder
Monteiro, W., Noshirvani, H., Marks, I. M., & Lelliott, P. T. (1987) · The British Journal of Psychiatry · doi:10.1192/bjp.151.1.107 · Cited by 202
Effect of Buspirone on Sexual Dysfunction in Depressed Patients Treated With Selective Serotonin Reuptake Inhibitors
Landén, M., Eriksson, E., Agren, H., & Fahlén, T. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00012 · Cited by 202
Drug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Ben-Ami, H., Nagachandran, P., Mendelson, A., & Edoute, Y. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.281 · Cited by 201
Sildenafil
Langtry, H. D., & Markham, A. (1999) · Drugs · doi:10.2165/00003495-199957060-00015 · Cited by 200
Sexual dysfunctions in depression
Mathew, R. J., & Weinman, M. L. (1982) · Archives of Sexual Behavior · doi:10.1007/bf01541593 · Cited by 196
Withdrawal syndromes associated with antipsychotic drugs
Gárdos, G., Jo, C., & Tarsy, D. (1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.11.1321 · Cited by 192
Tardive dyskinesia: summary of a Task Force Report of the American Psychiatric Association. By the Task Force on Late Neurological Effects of Antipsychotic Drugs
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.10.1163 · Cited by 192
Effects of Antidepressant Medication on Sexual
Harrison, W. M., Rabkin, J. G., Ehrhardt, A. Α., Stewart, J. W., McGrath, P. J., Ross, D. C., & Quitkin, F. M. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198606000-00004 · Cited by 188
Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
Feiger, A. D., Kiev, A., Shrivastava, R. K., Wisselink, P., & Wilcox, C. S. (1996) · PubMed · Cited by 185
Metoclopramide-induced movement disorders. Clinical findings with a review of the literature
Miller, L. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.11.2486 · Cited by 179
Fluoxetine-induced sexual dysfunction.
Herman, J. B., Brotman, A. W., Pollack, M. H., Falk, W. E., Biederman, J., & Rosenbaum, J. F. (1990) · PubMed · Cited by 179
Variations in compliance among hypertensive patients by drug class: implications for health care costs
Rizzo, J. A., & Robert Simons, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80018-5 · Cited by 174
Selective serotonin reuptake inhibitors in the treatment of affective disorders—III. Tolerability, safety and pharmacoeconomics
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
Coleman, C. C., King, B., Bolden-Watson, C., Book, M. J., Segraves, R., Richard, N., Ascher, J., Batey, S. R., Jamerson, B., & Metz, A. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80090-4 · Cited by 171
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday
Rothschild, A. J. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1514 · Cited by 168
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.
Faure, P., Rossini, E., Wiernsperger, N., Richard, M. J., Favier, A., & Halimi, S. (1999) · Diabetes · doi:10.2337/diabetes.48.2.353 · Cited by 166
Sexual dysfunction during antidepressant treatment
Balon, R. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)91203-4 · Cited by 163
Benzodiazepine withdrawal: outcome in 50 patients
ASHTON, H. (1987) · British Journal of Addiction · doi:10.1111/j.1360-0443.1987.tb01529.x · Cited by 160
Combining Serotonin Reuptake Inhibitors and Bupropion in Partial Responders to Antidepressant Monotherapy
Bodkin, J. A., Lasser, R. A., Wines, J. D., Gardner, D. M., & Baldessarini, R. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0401 · Cited by 159
Bupropion as an Antidote for Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction
Ashton, A. K., & Rosen, R. C. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0304 · Cited by 154
Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies
Soldatos, C. R., Dikeos, D. G., & Whitehead, A. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199909000-00004 · Cited by 154
Risk of Meningococcal Infection in College Students
Harrison, L. H. (1999) · JAMA · doi:10.1001/jama.281.20.1906 · Cited by 154
Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein, D. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00322-8 · Cited by 151
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
Kavoussi, R. J., Segraves, R. T., Hughes, A. R., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1204 · Cited by 149
Chronic Excessive Acetaminophen Use and Liver Damage
BARKER, J. D., de CARLE, D. J., & ANURAS, S. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-3-299 · Cited by 142
Metoclopramide-Induced Movement Disorders
Miller, L. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390110070015 · Cited by 139
Rhabdomyolysis from the Coadministration of Lovastatin and the Antifungal Agent Itraconazole
Lees, R. S., & Lees, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331015 · Cited by 136
An Open Trial of Oral Sildenafilin Antidepressant-Induced Sexual Dysfunction
D, M. F. M., Rankin, M. A., Alpert, J. E., Nierenberg, A. A., & Worthington, J. J. (1998) · Psychotherapy and Psychosomatics · doi:10.1159/000012299 · Cited by 135
Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients
Ashton, A. K., Hamer, R. M., & Rosen, R. C. (1997) · Journal of Sex & Marital Therapy · doi:10.1080/00926239708403922 · Cited by 133
Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion.
Walker, P. W., Cole, J. O., Gardner, E. A., Hughes, A. R., Johnston, J. A., Batey, S. R., & Lineberry, C. G. (1993) · PubMed · Cited by 132
Sexual Dysfunction Associated with the Treatment of Depression: A Placebo-Controlled Comparison of Bupropion Sustained Release and Sertraline Treatment
Coleman, C. C., Cunningham, L. A., Foster, V. J., Batey, S. R., Donahue, R. M. J., Houser, T. L., & Ascher, J. A. (1999) · Annals of Clinical Psychiatry · doi:10.1023/a:1022309428886 · Cited by 131
Female Sexual Dysfunction Associated With Antidepressant Administration: A Randomized, Placebo-Controlled Study of Pharmacologic Intervention
Michelson, D., Bancroft, J., Targum, S. D., Kim, Y., & Tepner, R. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.2.239 · Cited by 125
Severe cases of neuroleptic-induced supersensitivity psychosis
Chouinard, G. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90050-2 · Cited by 123
The role of serotonin in sexual dysfunction: fluoxetine-associated orgasm dysfunction.
Zajecka, J., Fawcett, J., Schaff, M., Jeffriess, H., & Guy, C. (1991) · PubMed · Cited by 122
Mirtazapine Substitution in SSRI-Induced Sexual Dysfunction
Gelenberg, A. J., Laukes, C., McGahuey, C., Okayli, G., Moreno, F., Zentner, L., & Delgado, P. L. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0506 · Cited by 122
Sexual side effects of antidepressants.
Rothschild, A. J. (2000) · PubMed · Cited by 117
Sexual Dysfunction Induced by Serotonin Reuptake Antidepressants
Labbate, L. A., Grimes, J. B., Hiaes, A., Oleshansky, M. A., & Arana, G. W. (1998) · Journal of Sex & Marital Therapy · doi:10.1080/00926239808414663 · Cited by 115
Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine
Smith, R. C., & Davis, J. M. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90170-3 · Cited by 111
Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers.
Hollander, E., & McCarley, A. (1992) · PubMed · Cited by 107
Sexual Dysfunction Associated with the Treatment of Depression: A Placebo-Controlled Comparison of Bupropion Sustained Release and Sertraline Treatment
Coleman, C., Cunningham, L., Foster, V., et al. (1999) · Annals of Clinical Psychiatry · doi:10.3109/10401239909147072 · Cited by 105
A Comparison of Nefazodone and Fluoxetine on Mood and on Objective, Subjective, and Clinician-Rated Measures of Sleep in Depressed Patients: A Double-Blind, 8-Week Clinical Trial
Gillin, J. C., Rapaport, M., Erman, M. K., Winokur, A., & Albala, B. J. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0502 · Cited by 104
Antidepressant-induced sexual dysfunction.
Segraves, R. T. (1998) · PubMed · Cited by 103
Fluoxetine-induced sexual dysfunction.
Patterson, W. M. (1993) · PubMed · Cited by 97
Acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer
Rao, R. K. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03972.x · Cited by 95
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Zajecka, J., Mitchell, S., & FAWCETT, J. A. (1997) · PubMed · Cited by 93
Buspirone treatment of sexual dysfunction associated with selective serotonin re‐uptake inhibitors
Norden, M. J. (1994) · Depression · doi:10.1002/depr.3050020208 · Cited by 91
Evaluation of Sexual Functioning in Depressed Outpatients: A Double-Blind Comparison of Sustained-Release Bupropion and Sertraline Treatment
Segraves, R. T., Kavoussi, R. J., Hughes, A. R., Batey, S. R., Johnston, J. A., Donahue, R. M. J., & Ascher, J. A. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00002 · Cited by 90
A Double-Blind Comparison of Fluvoxamine and Paroxetine in the Treatment of Depressed Outpatients
Kiev, A., & Feiger, A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0402 · Cited by 89
Sexual Functioning in Chronically Depressed Patients Treated With SSRI Antidepressants: A Pilot Study
Piazza, L. A., Markowitz, J. C., Kocsis, J. H., Leon, A. C., S, L. P. M., Miller, N. L., & Adler, D. G. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.12.1757 · Cited by 88
Apparent Potentiation of Acetaminophen Hepatotoxicity by Alcohol
LICHT, H., SEEFF, L. B., & ZIMMERMAN, H. J. (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-4-511_1 · Cited by 88
Treatment of fluoxetine-induced anorgasmia with amantadine.
Balogh, S. E., Hendricks, S. E., & Kang, J. S. (1992) · PubMed · Cited by 83
Cyproheptadine Treatment of Sexual Dysfunction Induced by Serotonin Reuptake Inhibitors
Aizenberg, D., Zemishlany, Z., & Weizman, A. (1995) · Clinical Neuropharmacology · doi:10.1097/00002826-199508000-00003 · Cited by 77
Treatment of Fluoxetine-Induced Sexual Dysfunction with Bupropion: A Case Report
Labbate, L. A., & Pollack, M. H. (1994) · Annals of Clinical Psychiatry · doi:10.3109/10401239409148833 · Cited by 74
Bupropion Treatment of Serotonin Reuptake Antidepressant-Associated Sexual Dysfunction
Labbate, L. A., Grimes, J. B., Hines, A., & Pollack, M. H. (1997) · Annals of Clinical Psychiatry · doi:10.1023/a:1022356427242 · Cited by 73
Cardiovascular Responses of Hyperactive Children to Methylphenidate
Ballard, J. E. (1976) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1976.03270260026021 · Cited by 72
Small weight loss on long-term acarbose therapy with no change in dietary pattern or nutrient intake of individuals with non-insulin-dependent diabetes
Wolever, T., Chiasson, J.-L., Josse, R., Hunt, J., Palmason, C., Rodger, N., Ross, S., Ryan, E., & Tan, M. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800468 · Cited by 71
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance
Revankar, S. G., Kirkpatrick, W. R., McAtee, R. K., Dib, O. P., Fothergill, A. W., Redding, S. W., Rinaldi, M. G., Hilsenbeck, S. G., & Patterson, T. F. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00137-5 · Cited by 67
Clinical Implications of Antidepressant Drug Effects on Sexual Function
Harvey, K., & Balon, R. (1995) · Annals of Clinical Psychiatry · doi:10.3109/10401239509149625 · Cited by 66
Management of SSRI-Induced Sexual Dysfunction
Woodrum, S. T., & Brown, C. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17428 · Cited by 65
Tardive dyskinesia associated with metoclopramide.
Wiholm, B. ‐., Mortimer, Ö., Boëthius, G., & Häggström, J. E. (1984) · BMJ · doi:10.1136/bmj.288.6416.545 · Cited by 58
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders
Labbate, L. A., Grimes, J. B., & Arana, G. W. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00391-0 · Cited by 58
Intermittent amantadine for fluoxetine-induced anorgasmia
Balon, R. (1996) · Journal of Sex & Marital Therapy · doi:10.1080/00926239608404410 · Cited by 58
Adherence to a Prophylactic Medication Regimen in Patients With Symptomatic Versus Asymptomatic Ischemic Heart Disease
Carney, R. M., Freedland, K. E., Eisen, S. A., Rich, M. W., Skala, J. A., & Jaffe, A. S. (1998) · Behavioral Medicine · doi:10.1080/08964289809596379 · Cited by 58
The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin reuptake inhibitor treatment due to sexual dysfunction
Koutouvidis, N., Pratikakis, M., & Fotiadou, A. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199907000-00008 · Cited by 55
Bupropion Treatment of Serotonin Reuptake Antidepressant-Associated Sexual Dysfunction
Labbate, L. A., Grimes, J. B., Hines, A., et al. (1997) · Annals of Clinical Psychiatry · doi:10.3109/10401239709147804 · Cited by 54
A controlled comparison of sertraline and fluoxetine in acute and continuation treatment of major depression
Moffaert, M. V., Bartholomé, F., Cosyns, P. R., Nayer, A. R. D., & Mertens, C. (1995) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.470100505 · Cited by 51
Effects of single and long-term metoclopramide administration on open field and stereotyped behavior of rats
Frussa‐Filho, R., & Palermo‐Neto, J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90663-2 · Cited by 46
Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
Chouinard, G., Annable, L., & Ross‐Chouinard, A. (1986) · PubMed · Cited by 45
Is there a limbic system equivalent of tardive dyskinesia?
Kl, D., & Rosenberg, G. S. (1979) · PubMed · Cited by 45
New directions in the treatment of antidepressant-induced sexual dysfunction
Rothschild, A. J. (2000) · Clinical Therapeutics · doi:10.1016/s0149-2918(00)80072-7 · Cited by 45
Oral Morphine for Relief of Chronic Pain from Cancer
Walsh, D., & Saunders, C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052317 · Cited by 44
Evaluating the Tolerability of the Newer Antidepressants
Dewan, M. J., & ANAND, V. S. (1999) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199902000-00005 · Cited by 43
Cyproheptadine for Imipramine-Induced Anorgasmia
&NA; (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198610000-00027 · Cited by 42
The Concept of Supersensitivity Psychosis
Kirkpatrick, B. W., Alphs, L. D., & Buchanan, R. W. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199204000-00009 · Cited by 41
Care of the sexually active depressed patient.
Hirschfeld, R. M. A. (1999) · PubMed · Cited by 37
Relief of SSRI-Induced Sexual Dysfunction With Mirtazapine Treatment
Farah, A. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412a · Cited by 36
The potential benefits of serotonin receptor-specific agents.
Sussman, N. (1994) · PubMed · Cited by 29
Neuroleptic‐induced supersensitivity psychosis in patients with bipolar affective disorder
Steiner, W., Laporta, M., & Chouinard, G. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05477.x · Cited by 26
Fluvoxamine-induced erectile dysfunction responding to sildenafil
Balon, R. (1998) · Journal of Sex & Marital Therapy · doi:10.1080/00926239808403967 · Cited by 25
Neurotransmitter, opiodergic system, steroid-hormone interaction and involvement in the replacement therapy of sexual disorders
Frajese, G., Lazzari, R., Magnani, A., Moretti, C., Sforza, V., & Nerozzi, D. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90492-4 · Cited by 25
Hypothalamic dopamine receptor supersensitivity? A pilot study of self-induced water intoxication.
Ww, S., & Ls, S. (1983) · PubMed · Cited by 23
A controlled study of the effects of antidepressants on sexual function.
Wm, H., Stewart, J. R., Ehrhardt, A. A., Rabkin, J. G., McGrath, P. J., Liebowitz, M. R., & Quitkin, F. M. (1985) · PubMed · Cited by 23
Parkinsonism and Tardive Dyskinesia Associated with Long-Term Metoclopramide Therapy
Grimes, J. D. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052316 · Cited by 22
Dopamine receptor supersensitivity and the chemoreceptor trigger zone.
Shen, W. W., Baig, M. S., Sata, L. S., et al. (1983) · PubMed · Cited by 21
Sildenafil Treatment of Paroxetine-Induced Anorgasmia in a Woman
Ashton, A. K. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.800 · Cited by 21
Antidepressant-Induced Sexual Dysfunction: Review, Classification, and Suggestions for Treatment
Ellison, J. M. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000328 · Cited by 18
Fluoxetine-induced sexual dysfunction and yohimbine.
Balon, R. (1993) · PubMed · Cited by 17
Psychosis after neuroleptic withdrawal in a manic-depressive patient
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.105 · Cited by 16
Anorgasmia caused by an MAOI
Jacobson, J. N. (1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.4.527a · Cited by 12
Schizophrenia following Withdrawal from Chronic Phenothiazine Administration: A Case Report
Sale, I., & Kristall, H. (1978) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048677809159594 · Cited by 11
Sildenafil and sexual dysfunction associated with antidepressants
Balon, R. (1999) · Journal of Sex & Marital Therapy · doi:10.1080/00926239908404001 · Cited by 11
Phenelzine-induced sexual dysfunction treated with sildenafil
Gupta, S., Masand, P. S., Ashton, A. K., & Berry, S. L. (1999) · Journal of Sex & Marital Therapy · doi:10.1080/00926239908403986 · Cited by 9
Safety of Sildenafil for Antidepressant-Related Sexual Dysfunction
Pies, R. W. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1114 · Cited by 8

Flagged first, then by citations

Research works printed but not linked: 21

Preskorn SH, 1995, J Clin Psychiatry, 56, 12
Patterson WM, 1993, J Clin Psychiatry, 54, 71
Feiger A, 1996, J Clin Psychiatry, 57, 53
Zajecka J, 1991, J Clin Psychiatry, 52, 66
Herman JB, 1990, J Clin Psychiatry, 51, 25
Segraves RT, 1998, J Clin Psychiatry, 59, 48
Segraves RT, 1993, J Clin Psychiatry Monogr, 11, 57
Rothschild AJ, 2000, J Clin Psychiatry, 61, 28
Hirschfeld RM, 1999, J Clin Psychiatry, 60, 32
Reimherr FW, 1990, J Clin Psychiatry, 51, 18
1994, Diagnostic and statistical manual for psychiatric disorders
Harrison WM, 1985, Psychopharmacol Bull, 21, 85
Balon R, 1993, J Clin Psychiatry, 54, 209
Zajecka J, 1997, Psychopharmacol Bull, 33, 755
Jacobsen FM, 1992, J Clin Psychiatry, 53, 119
Walker PW, 1993, J Clin Psychiatry, 54, 459
1999, Delphi Panel investigation of antidepressant related sexual dysfunction and breakthrough symptoms
Balon R, 1993, J Clin Psychiatry, 54, 161
Hollander E, 1992, J Clin Psychiatry, 53, 207
Balogh S, 1992, J Clin Psychiatry, 53, 212
Sussman N, 1994, J Clin Psychiatry, 55, 45

Sorted by citations

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
DE HERT, M., CORRELL, C. U., BOBES, J., CETKOVICH‐BAKMAS, M., COHEN, D., ASAI, I., DETRAUX, J., GAUTAM, S., MÖLLER, H., NDETEI, D. M., et al. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00014.x · Cited by 2,488
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928
Statin-associated myopathy
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463
Collaborative care for depression and anxiety problems
Archer, J., Bower, P., Gilbody, S., Lovell, K., Richards, D., Gask, L., Dickens, C., & Coventry, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006525.pub2 · Cited by 1,126
The Mediterranean Diet, its Components, and Cardiovascular Disease
Widmer, R. J., Flammer, A. J., Lerman, L. O., & Lerman, A. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.10.014 · Cited by 963
“A multitude of meta-analyses have shown a potential cardiovascular disease morbidity and mortality benefit for mainly secondary prevention with increased fish intake (19-28).”
Background
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson, I. M., Ferrier, I. N., Baldwin, R., Cowen, P. J., Howard, L. M., Lewis, G., Matthews, K., McAllister-Williams, H., Peveler, R. C., Scott, J. L., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 909
Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
Graham, D. J. (2004) · JAMA · doi:10.1001/jama.292.21.2585 · Cited by 875
Statin Safety: A Systematic Review
Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Cleare, A., Pariante, C., Young, A., Anderson, I., Christmas, D., Cowen, P., Dickens, C., Ferrier, I., Geddes, J., Gilbody, S., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581093 · Cited by 759
Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis
Mayo-Wilson, E., Dias, S., Mavranezouli, I., Kew, K., Clark, D. M., Ades, A. E., & Pilling, S. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70329-3 · Cited by 680
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Safety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578
Premenstrual syndrome
Yonkers, K. A., O’Brien, P. M. S., & Eriksson, E. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60527-9 · Cited by 593
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., et al. (2014) · Pain Research and Management · doi:10.1155/2014/754693 · Cited by 529
A review of drug-induced hyponatremia
Liamis, G., Milionis, H., & Elisaf, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.004 · Cited by 499
Self-citation
American Association Of Clinical Endocrinologists And American Association Of Endocrine Surgeons Medical Guidelines For The Management Of Adrenal Incidentalomas
Zeiger, M. A., Thompson, G. B., Duh, Q.-Y., Hamrahian, A. H., Angelos, P., Elaraj, D., Fishman, E., Kharlip, J., Zeiger, M. A., Thompson, G. B., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s1.1 · Cited by 499
A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor
Stahl, S. M., Pradko, J., Haight, B. R., Modell, J. G., Rockett, C. B., & Learned-Coughlin, S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0403 · Cited by 495
Collaborative care for depression in primary care: Making sense of a complex intervention: systematic review and meta-regression
Bower, P., Gilbody, S., Richards, D., Fletcher, J., & Sutton, A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.106.023655 · Cited by 429
Physician communication when prescribing new medications
Tarn, D. M., Heritage, J., Paterniti, D. A., Hays, R. D., Kravitz, R. L., & Wenger, N. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.17.1855 · Cited by 400
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force On Treatment Guidelines For Bipolar Disorders (2010) · The World Journal of Biological Psychiatry · doi:10.3109/15622970903555881 · Cited by 399
Relationship of Blood Pressure Control to Adherence With Antihypertensive Monotherapy in 13 Managed Care Organizations
Bramley, T. J., Nightengale, B. S., Frech-Tamas, F., & Gerbino, P. P. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.3.239 · Cited by 380
Outpatient gatifloxacin therapy and dysglycemia in older adults.
Park-Wyllie, L. Y., Juurlink, D. N., Kopp, A., Shah, B. R., Stukel, T. A., Stumpo, C., Dresser, L., Low, D. E., & Mamdani, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055191 · Cited by 367
Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe
Castedo, M., Perfettini, J.-L., Roumier, T., & Kroemer, G. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401130 · Cited by 345
Sexual Dysfunction, Depression, and the Impact of Antidepressants
Kennedy, S. H., & Rizvi, S. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819c76e9 · Cited by 338
Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy
Cella, D., & Fallowfield, L. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9548-1 · Cited by 286
Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs: A Retrospective Analysis among Managed Care Patients with Chronic Myelogenous Leukaemia
Darkow, T., Henk, H. J., Thomas, S. K., Feng, W., Baladi, J.-F., Goldberg, G. A., Hatfield, A., & Cortes, J. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725060-00004 · Cited by 271
Safer Healthcare
Vincent, C., & Amalberti, R. (2016) · doi:10.1007/978-3-319-25559-0 · Cited by 278
Gender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267
Toxicity of statins on rat skeletal muscle mitochondria
Kaufmann, P., Török, M., Zahno, A., Waldhauser, K. M., Brecht, K., & Krähenbühl, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6235-z · Cited by 263
Statin Safety: An Overview and Assessment of the Data—2005
Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264
Psychosocial Intervention Improves Depression, Quality of Life, and Fluid Adherence in Hemodialysis
Cukor, D., Ver Halen, N., Asher, D. R., Coplan, J. D., Weedon, J., Wyka, K. E., Saggi, S. J., & Kimmel, P. L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111134 · Cited by 263
Genetic risk factors associated with lipid-lowering drug-induced myopathies
Vladutiu, G. D., Simmons, Z., Isackson, P. J., Tarnopolsky, M., Peltier, W. L., Barboi, A. C., Sripathi, N., Wortmann, R. L., & Phillips, P. S. (2006) · Muscle & Nerve · doi:10.1002/mus.20567 · Cited by 253
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?
Murray, R. M., Quattrone, D., Natesan, S., van Os, J., Nordentoft, M., Howes, O., Di Forti, M., & Taylor, D. (2016) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.182683 · Cited by 244
The clinical implications of ageing for rational drug therapy
Shi, S., Mörike, K., & Klotz, U. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0422-1 · Cited by 244
Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal‐related relapse
Moncrieff, J. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00787.x · Cited by 231
Antidepressant-associated sexual dysfunction: impact, effects, and treatment
Higgins, A. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s7634 · Cited by 227
Strategies for managing sexual dysfunction induced by antidepressant medication
Taylor, M. J., Rudkin, L., Bullemor-Day, P., Lubin, J., Chukwujekwu, C., & Hawton, K. E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003382.pub3 · Cited by 231
Sexuality in older age: essential considerations for healthcare professionals
Taylor, A., & Gosney, M. (2011) · Age and Ageing · doi:10.1093/ageing/afr049 · Cited by 226
A biopsychosocial approach to women’s sexual function and dysfunction at midlife: A narrative review
Thomas, H. N., & Thurston, R. C. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.02.009 · Cited by 243
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States
Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10386 · Cited by 222
A history of being prescribed controlled substances and risk of drug overdose death
Paulozzi, L. J., Kilbourne, E. M., Shah, N. G., Nolte, K. B., Desai, H. A., Landen, M. G., Harvey, W., & Loring, L. D. (2012) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01260.x · Cited by 221
Tolerability and adherence issues in antidepressant therapy
Masand, P. S. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80220-5 · Cited by 215
Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: A systematic review and meta-analysis
Oliva, V., Lippi, M., Paci, R., Del Fabro, L., Delvecchio, G., Brambilla, P., De Ronchi, D., Fanelli, G., & Serretti, A. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110266 · Cited by 219
The vigilance regulation model of affective disorders and ADHD
Hegerl, U., & Hensch, T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.008 · Cited by 212
A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR
Kennedy, S. H., Rizvi, S. J., Fulton, K., & Rasmussen, J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318172b48c · Cited by 211
Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects.
Yasuda, H., Yuen, P. S. T., Hu, X., Zhou, H., & Star, R. A. (2006) · Kidney International · doi:10.1038/sj.ki.5000300 · Cited by 209
Depression and anxiety in children and adolescents with epilepsy: Prevalence, risk factors, and treatment
Ekinci, O., Titus, J. B., Rodopman, A. A., Berkem, M., & Trevathan, E. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.08.015 · Cited by 186
HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT
Goodman, C. S., & Church, F. (2004) · Cited by 185
Self-citation
Differentiating antidepressants of the future: Efficacy and safety
Rosenzweig-Lipson, S. J., Beyer, C. E., Hughes, Z. A., Khawaja, X. Z., Rajarao, S. J. R., Malberg, J. E., Rahman, Z. U., Ring, R. H., & Schechter, L. E. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.07.002 · Cited by 185
Frequency of Attendance at Religious Services and Mortality in a U.S. National Cohort
Gillum, R. F., King, D. E., Obisesan, T. O., & Koenig, H. G. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.10.015 · Cited by 176
Self-citation
Sexual dysfunction in the elderly: age or disease?
Camacho, M. E., & Ortiz, C. A. R. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901429 · Cited by 178
Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery
Greer, C. B., Tanaka, Y., Kim, Y. J., Xie, P., Zhang, M. Q., Park, I.-H., & Kim, T. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.013 · Cited by 174
Functional neuroimaging of reward circuitry responsivity to monetary gains and losses in posttraumatic stress disorder
Elman, I., Lowen, S., Frederick, B. B., Chi, W., Becerra, L., & Pitman, R. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.006 · Cited by 165
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients
Sartelli, M., Di Bella, S., McFarland, L. V., Khanna, S., Furuya-Kanamori, L., Abuzeid, N., Abu-Zidan, F. M., Ansaloni, L., Augustin, G., Bala, M., et al. (2019) · World Journal of Emergency Surgery · doi:10.1186/s13017-019-0228-3 · Cited by 159
Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia
Draeger, A., Monastyrskaya, K., Mohaupt, M., Hoppeler, H., Savolainen, H., Allemann, C., & Babiychuk, E. (2006) · The Journal of Pathology · doi:10.1002/path.2018 · Cited by 163
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
Reichenpfader, U., Gartlehner, G., Morgan, L. C., Greenblatt, A., Nussbaumer, B., Hansen, R. A., Van Noord, M., Lux, L., & Gaynes, B. N. (2014) · Drug Safety · doi:10.1007/s40264-013-0129-4 · Cited by 160
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse
Horowitz, M. A., Jauhar, S., Natesan, S., Murray, R. M., & Taylor, D. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab017 · Cited by 157
Antiarrhythmic effects of omega-3 fatty acids
Reiffel, J. A., & McDonald, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.027 · Cited by 153
A hypothesis of monoamine (5-HT) – Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery
Li, Y.-F. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107494 · Cited by 155
Changes in Sexual Functioning Associated with Duloxetine, Escitalopram, and Placebo in the Treatment of Patients with Major Depressive Disorder
Clayton, A. H., Kornstein, S. G., Prakash, A., Mallinckrodt, C. H., & Wohlreich, M. M. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00520.x · Cited by 152
Agomelatine in the Treatment of Major Depressive Disorder
Kennedy, S. H., & Rizvi, S. J. (2010) · CNS Drugs · doi:10.2165/11534420-000000000-00000 · Cited by 151
Rates of 5 Common Antidepressant Side Effects Among New Adult and Adolescent Cases of Depression: A Retrospective US Claims Study
Anderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.024 · Cited by 147
Randomised Controlled Trial of a Collaborative Care Model with Psychiatric Consultation for Persistent Medically Unexplained Symptoms in General Practice
van der Feltz-Cornelis, C. M., van Oppen, P., Adèr, H. J., & van Dyck, R. (2006) · Psychotherapy and Psychosomatics · doi:10.1159/000093949 · Cited by 138
Molecular analysis of nicotinic receptor expression in autism
Martin-Ruiz, C. M., Lee, M., Perry, R. H., Baumann, M., Court, J. A., & Perry, E. K. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.01.003 · Cited by 141
Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort study
Giltay, E. J., Enter, D., Zitman, F. G., Penninx, B. W. J. H., PELT, J. V., Spinhoven, P., & Roelofs, K. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.014 · Cited by 149
A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures
Piette, J. D., Heisler, M., Horne, R., & Caleb Alexander, G. (2006) · Social Science & Medicine · doi:10.1016/j.socscimed.2005.06.045 · Cited by 138
Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder
Cutler, A. J., Montgomery, S., Feifel, D., Lazarus, A. L., Åström, M., & Brecher, M. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04592 · Cited by 137
Side Effects of Atypical Antipsychotics: Extrapyramidal Symptoms and the Metabolic Syndrome
Shirzadi, A. A., & Ghaemi, S. N. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600748486 · Cited by 133
Tablet-splitting: a common yet not so innocent practice
Verrue, C., Mehuys, E., Boussery, K., Remon, J.-P., & Petrovic, M. (2011) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05477.x · Cited by 134
Modafinil Augmentation Therapy in Unipolar and Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Goss, A. J., Kaser, M., Costafreda, S. G., Sahakian, B. J., & Fu, C. H. Y. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08560 · Cited by 133
Review: Bupropion and SSRI-induced side effects
Demyttenaere, K., & Jaspers, L. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107083798 · Cited by 134
“Several methodological issues complicate the search for a reliable prevalence-estimate, and make it difficult to compare the numerous reports in the field (Baldwin, 2001; Gregorian et al., 2002; Montgomery et al., 2002; Balon, 2006).”
Result
The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: a review
Olivier, J. D. A., Blom, T., Arentsen, T., & Homberg, J. R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.013 · Cited by 131
“These effects correspond to fluoxetine's clinical effects (e.g. Vaswani et al., 2003; Walsh and Dinan, 2001; Gregorian et al., 2002) (Table 1), although they may depend on the genetic background of the rodent strain that is used.”
Background
Statin safety: an assessment using an administrative claims database
Cziraky, M. J., Willey, V. J., McKenney, J. M., Kamat, S. A., Fisher, M. D., Guyton, J. R., Jacobson, T. A., & Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.011 · Cited by 130
Risk Factors Associated with Primary and Secondary Reduced Libido in Male Patients with Sexual Dysfunction
Corona, G., Rastrelli, G., Ricca, V., Jannini, E. A., Vignozzi, L., Monami, M., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12043 · Cited by 128
Sexual dysfunction associated with major depressive disorder and antidepressant treatment
Clayton, A. H., Haddad, S. E., Iluonakhamhe, J.-P., Martinez, C. C. P., & Schuck, A. E. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.951324 · Cited by 133
Sexual Activity and Aging
Lochlainn, M. N., & Kenny, R. A. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.01.022 · Cited by 137
Pharmacology and perspectives in erectile dysfunction in man
Mitidieri, E., Cirino, G., Bianca, R. D. D. V., & Sorrentino, R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107493 · Cited by 129
Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self controlled case series study
Shin, J.-Y., Roughead, E. E., Park, B.-J., & Pratt, N. L. (2016) · BMJ · doi:10.1136/bmj.i2550 · Cited by 122
The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder
Kingsberg, S. A., Clayton, A. H., & Pfaus, J. G. (2015) · CNS Drugs · doi:10.1007/s40263-015-0288-1 · Cited by 127
Primum Non Nocere: An Evolutionary Analysis of Whether Antidepressants Do More Harm than Good
Andrews, P. W., Thomson, J. A., Amstadter, A., & Neale, M. C. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00117 · Cited by 120
The Madness of Women: Myth and Experience
Ussher, J. M. (2022) · Springer eBooks · doi:10.1007/978-981-16-7255-2_34 · Cited by 120
Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
Winterstein, A. G., Gerhard, T., Shuster, J., Johnson, M., Zito, J. M., & Saidi, A. (2007) · Pediatrics · doi:10.1542/peds.2007-0675 · Cited by 119
Management of Hot Flashes in Patients Who Have Breast Cancer With Venlafaxine and Clonidine: A Randomized, Double-Blind, Placebo-Controlled Trial
Boekhout, A. H., Vincent, A. D., Dalesio, O., Bosch, J., Foekema-Töns, J. H., Adriaansz, S., Sprangers, S., Nuijen, B., Beijnen, J. H., & Schellens, J. H. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1298 · Cited by 117
Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment
Möller, H. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970801981606 · Cited by 117
Selective Serotonin Reuptake Inhibitor Discontinuation: Side Effects and Other Factors That Influence Medication Adherence
Goethe, J. W., Woolley, S. B., Cardoni, A. A., Woznicki, B. A., & Piez, D. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815152a5 · Cited by 113
Statin safety: an appraisal from the adverse event reporting system
Davidson, M. H., Clark, J. A., Glass, L. M., & Kanumalla, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.008 · Cited by 113
Drug–target interaction predication via multi-channel graph neural networks
Li, Y., Qiao, G., Wang, K., & Wang, G. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab346 · Cited by 112
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations
Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112
Initiation of antidepressant therapy: do patients follow the GP's prescription?
van Geffen, E. C., Gardarsdottir, H., van Hulten, R., van Dijk, L., Egberts, A. C., & Heerdink, E. R. (2009) · British Journal of General Practice · doi:10.3399/bjgp09x395067 · Cited by 107
Burden of phase-specific sexual dysfunction with SSRIs☆
Clayton, A. H., KELLER, A., & McGarvey, E. L. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.007 · Cited by 109
Sexual Dysfunction in an Internet Sample of U.S. Men Who Have Sex with Men
Hirshfield, S., Chiasson, M. A., Wagmiller, R. L., Remien, R. H., Humberstone, M., Scheinmann, R., & Grov, C. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01636.x · Cited by 109
A Double-Blind Comparison of Escitalopram and Paroxetine in the Long-Term Treatment of Generalized Anxiety Disorder
Bielski, R. J., Bose, A., & Chang, C.-C. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230590932326 · Cited by 109
Spinal cord control of ejaculation
Allard, J., Truitt, W. A., McKenna, K. E., & Coolen, L. M. (2005) · World Journal of Urology · doi:10.1007/s00345-004-0494-9 · Cited by 108
Current Concepts in Pharmacotherapy for Posttraumatic Stress Disorder
Schoenfeld, F. B., Marmar, C. R., & Neylan, T. C. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.5.519 · Cited by 107
Anti-Inflammatory and Anticancer Drugs from Nature
Orlikova, B., Legrand, N., Panning, J., Dicato, M., & Diederich, M. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_8 · Cited by 108
Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomised controlled trials
Taylor, M. J., Rudkin, L., & Hawton, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.006 · Cited by 102
“Further information on rates of sexual dysfunction with antidepressants can be found elsewhere (Montgomery et al., 2002; Gregorian et al., 2002).”
Background
Can paracetamol (acetaminophen) be administered to patients with liver impairment?
Hayward, K. L., Powell, E. E., Irvine, K. M., & Martin, J. H. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12802 · Cited by 104
Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study
Bruno, A., Micò, U., Pandolfo, G., Mallamace, D., Abenavoli, E., Di Nardo, F., D’Arrigo, C., Spina, E., Zoccali, R. A., & Muscatello, M. R. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431751 · Cited by 103
Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
Rys, P., Wojciechowski, P., Rogoz-Sitek, A., Niesyczyński, G., Lis, J., Syta, A., & Malecki, M. T. (2015) · Acta Diabetologica · doi:10.1007/s00592-014-0698-4 · Cited by 101

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction
Montgomery, S. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00313-5 · Cited by 205
Antidepressant-Induced Sexual Dysfunction: Review, Classification, and Suggestions for Treatment
Ellison, J. M. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809000328 · Cited by 18
Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction.
Montejo, A. L., Llorca, G., Izquierdo, J. A., & Rico‐Villademoros, F. (2001) · PubMed · Cited by 460
Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey
Williams, V. S. L., Baldwin, D. S., Hogue, S., Fehnel, S. E., Hollis, K. A., & Edin, H. M. (2006) · ePrints Soton (University of Southampton) · Cited by 3
Role of Receptor Binding Profiles in Antidepressant-Induced Sexual Dysfunction
Haberfellner, E. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0213e · Cited by 1

Authors: Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M.
Affiliations: Lewin Group (United States) (US)
Icahn School of Medicine at Mount Sinai (US)
GlaxoSmithKline (United States) (US)
GlaxoSmithKline (United Kingdom) (GB)
Corresponding author: Goodman, Clifford
ORCID: Goodman, Clifford
Venue: Annals of Pharmacotherapy
Publisher: SAGE Publications
Published: 2002-10
Volume: 36
Issue: 10
Pages: 1577-1589
ISSN: 0012-6578 (ISSN-L)
1060-0280
1542-6270
DOI: 10.1345/aph.1a195
OpenAlex: W2171466849
Cited by: 320
References: 71
Citations by year: 2026: 3 · 2025: 5 · 2024: 11 · 2023: 9 · 2022: 18 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 15 · 2017: 6 · 2016: 12 · 2015: 13 · 2014: 17 · 2013: 22 · 2012: 22
FWCI: 7.68
Type: journal article
Language: en
Open access: closed
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Annals of Pharmacotherapy (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: antidepressant-induced sexual dysfunction, selective serotonin reuptake inhibitors, adverse drug reactions, fluoxetine, sertraline, paroxetine, bupropion, nefazodone, mirtazapine, depression treatment, medication adherence
MeSH terms: Antidepressive Agents, Clinical Trials as Topic, Depressive Disorder, Female, Humans, Libido, Male, Selective Serotonin Reuptake Inhibitors, Sexual Dysfunctions, Psychological

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antidepressant-Induced Sexual Dysfunction

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks